Fliser D, Haller H
Abteilung Nephrologie, Zentrum für Innere Medizin, Medizinische Hochschule Hannover.
Internist (Berl). 2004 May;45(5):598-605. doi: 10.1007/s00108-003-1118-y.
Diuretics block different electrolyte transporters in renal tubular cells. Their predominant action is inhibition of renal sodium chloride reabsorption, however, and achievement of a negative body sodium balance is the principal goal of diuretic therapy in patients with hypertension and edema. Several classes of diuretics can be distinguished with respect to the sites of sodium reabsorption along the nephron, but loop diuretics and distal-tubular diuretics (incl. thiazides) are the most widely used. The latter have a less potent natriuretic effect than loop diuretics, but their long duration of action predispose them for treatment of patients with uncomplicated hypertension. In conditions of gross edema, e.g. heart and/or renal failure, distal-tubular diuretics lose their efficacy and must be replaced by or combined with loop diuretics ("sequential nephron blockade"). Aldosterone antagonists are unique among diuretics because they improve survival in patients with heart failure independently of their effect on sodium metabolism.
利尿剂可阻断肾小管细胞中不同的电解质转运体。然而,它们的主要作用是抑制肾脏对氯化钠的重吸收,实现机体负钠平衡是高血压和水肿患者利尿治疗的主要目标。根据沿肾单位钠重吸收的部位可区分出几类利尿剂,但袢利尿剂和远曲小管利尿剂(包括噻嗪类)是应用最广泛的。后者的排钠作用比袢利尿剂弱,但作用持续时间长,使其适用于治疗无并发症的高血压患者。在严重水肿的情况下,如心力衰竭和/或肾衰竭,远曲小管利尿剂会失去疗效,必须用袢利尿剂替代或与袢利尿剂联合使用(“连续肾单位阻断”)。醛固酮拮抗剂在利尿剂中独具特色,因为它们可提高心力衰竭患者的生存率,而与对钠代谢的影响无关。